Internap Corp Cmn (INAP) 2.23 $INAP Bristol-Myers

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 4:22 PM

Internap Corp Cmn (INAP) 2.23 $INAP

Bristol-Myers Squibb, Deutsche Bank, Alphabet, Blucora and Internap highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 8:30AM CDT
Bristol-Myers Squibb, Deutsche Bank, Alphabet, Blucora and Internap highlighted as Zacks Bull and Bear of the Day
DB: 13.30 (+0.33), GOOGL: 727.20 (+9.42), BMY: 75.39 (+0.11), INAP: 2.23 (-0.09), BCOR: 11.68 (+0.19)

Get Ready for Google's New Sugary Treat, Android Nougat
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 4:25PM CDT
Nougat is Alphabet Inc.'s (GOOGL) latest version of Android. The company announced the name on Snapchat Thursday.
GOOGL: 727.20 (+9.42), YRD: 15.77 (-0.02), INAP: 2.23 (-0.09)

Google Buys Clean Energy to Power European Datacenters
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 4:22PM CDT
Alphabet Inc. (GOOGL) owned Google announced that it has bought power output for its data centers in Europe from two wind power farms in Norway and Sweden.
GOOGL: 727.20 (+9.42), BCOR: 11.68 (+0.19), INAP: 2.23 (-0.09)

Apple (AAPL), Spotify Battle for Music Streaming Market
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 9:26AM CDT
Spotify has alleged that Apple (AAPL) has blocked an update to the former's iOS app in order to give an edge to its own service Apple Music.
AMZN: 753.78 (+7.97), P: 13.04 (-0.24), INAP: 2.23 (-0.09), AAPL: 96.98 (+0.30)

Oracle Prices Bonds Worth $14B; Moody's Outlook Negative
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:57AM CDT
Oracle Corporation (ORCL) recently announced the pricing of senior unsecured notes aggregating $14 billion.
CSLT: 4.22 (+0.21), INAP: 2.23 (-0.09), ORCL: 40.78 (-0.09), MCO: 97.85 (+1.12)

MeetMe (MEET) Stock Rallies on News of Skout Acquisition
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:16AM CDT
Shares of MeetMe Inc. (MEET) gained nearly 12% after the dating app operator announced its acquisition of one of its smaller competitors, Skout, on Monday.
MEET: 6.23 (+0.39), YRD: 15.77 (-0.02), BCOR: 11.68 (+0.19), INAP: 2.23 (-0.09)

Groupon (GRPN) to Boost Platform Using Splunk Technology
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:07AM CDT
Groupon, Inc. (GRPN) will be signing a multi-year Enterprise Adoption Agreement (EAA) with Splunk Inc. (SPLK).
CSLT: 4.22 (+0.21), SPLK: 57.36 (+0.73), GRPN: 3.45 (+0.05), INAP: 2.23 (-0.09)

Google Betters Data Management, Launches My Activity Site
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:04AM CDT
Alphabet Inc. (GOOGL) has decided to empower its users with improved data management and ad blocking options across all devices that they use for Google's search engine or other services.
GOOGL: 727.20 (+9.42), YRD: 15.77 (-0.02), INAP: 2.23 (-0.09)

Google May Face a New Set of Antitrust Charges from EU
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 5:13PM CDT
Alphabet Inc. (GOOGL) is likely to face a third set of formal antitrust charges from Europe's competition regulator, the European Union (EU).
GOOGL: 727.20 (+9.42), YRD: 15.77 (-0.02), INAP: 2.23 (-0.09), NWSA: 11.85 (+0.18)

Will Intel Offload its McAfee Cyber Security Division?
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 10:16AM CDT
Chip giant Intel Corporation (INTC) is reportedly considering the sale of Intel Security, its cyber security unit.
YRD: 15.77 (-0.02), INTC: 34.38 (+0.38), INAP: 2.23 (-0.09)

Groupon's (GRPN) OrderUp Partners Qdoba Mexican Eats
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:52AM CDT
Groupon, Inc. (GRPN) shares were up about 3.08% in yesterday's trading session after the company revealed its plans to expand OrderUp, its on-demand food delivery service.
CSLT: 4.22 (+0.21), GRPN: 3.45 (+0.05), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

Pitney Bowes' New Solutions to Drive Digital Transformation
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:43AM CDT
Pitney Bowes (PBI) launched a new family of "Communicate" solutions, which will enable organizations to transform their digital capabilities.
PBI: 17.99 (+0.19), KTCC: 7.46 (+0.02), ZIXI: 4.00 (+0.10), INAP: 2.23 (-0.09)

VeriFone Up on Wirecard Deal, Retains Focus on Indonesia
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 7:30AM CDT
VeriFone Systems, Inc. (PAY) rose nearly 4.3% in yesterday's trading session after the company announced that it has entered into a five-year strategic alliance with Germany-based electronic payment processing company, Wirecard AG.
CSLT: 4.22 (+0.21), PAY: 18.66 (+0.08), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

Internap (INAP) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:44AM CDT
As of late, it has definitely been a great time to be an investor in Internap Corporation (INAP)
INAP: 2.23 (-0.09)

Pandora Continues to March Higher on Buyout Speculation
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 9:20AM CDT
Music streaming pioneer, Pandora Media, Inc. (P) has started gaining momentum again.
AMZN: 753.78 (+7.97), P: 13.04 (-0.24), INAP: 2.23 (-0.09), AAPL: 96.98 (+0.30)

Groupon (GRPN) to Divest Indonesian Business to KFIt (revised)
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 4:07PM CDT
Groupon's Indonesian business is being acquired by KFit Holdings Pte Ltd, which itself is a one-year old startup.
CSLT: 4.22 (+0.21), GRPN: 3.45 (+0.05), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

VeriFone (PAY) Hits 52-Week Low on Cut in Fiscal 2016 View
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 10:17AM CDT
Shares of VeriFone Systems Inc. (PAY) tumbled nearly 25% and touched a 52-week low of $19.71 before closing at $21.27 in yesterday's trading session.
CSLT: 4.22 (+0.21), PAY: 18.66 (+0.08), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

VeriFone (PAY) Q2 Earnings Miss, Stock Falls on Q3 View Cut
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:58AM CDT
VeriFone (PAY) Q2 earnings missed estimates and the company lowered its outlook for fiscal 2016 as a result of which shares tanked nearly 28% in the after-hours trading session yesterday.
CSLT: 4.22 (+0.21), PAY: 18.66 (+0.08), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

Plexus Up on $150M Buyback Program, Reaffirms Q3 Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:58AM CDT
Plexus Corp. (PLXS) announced its plans to initiate a new $150 million share repurchase program while reaffirming its third quarter fiscal 2016 guidance yesterday.
PLXS: 44.21 (+0.29), CSLT: 4.22 (+0.21), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

Groupon (GRPN) to Divest its Indonesian Business to KFIt
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 7:17AM CDT
Groupon (GRPN) is divesting its Indonesian business to KFit Holdings for a strategic stake.
CSLT: 4.22 (+0.21), GRPN: 3.45 (+0.05), INAP: 2.23 (-0.09), TEAM: 27.21 (+0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...